The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / With Apps & Remote Medicine, Japan Offers Glimpse of Doctor Visits in Post-COVID-19 Era

With Apps & Remote Medicine, Japan Offers Glimpse of Doctor Visits in Post-COVID-19 Era

July 13, 2020 • By Kaori Kaneko & Izumi Nakagawa

  • Tweet
  • Email
Print-Friendly Version / Save PDF

“Ideally, medical care should be designed to provide necessary support for patients regardless of whether it is online or on site,” he says.

You Might Also Like
  • Telemedicine Company Wins Order Putting Texas Remote Treatment Rule on Hold
  • Japan PM’s Advisers Urge Annual Review of Drug Prices
  • Tight RA Control Via Telemedicine Noninferior to Conventional Clinic Visits

About 16,100 Japanese medical institutions excluding dentists—nearly 15% of all such facilities—offered remote medical services, including by telephone, as of early July, according to the health ministry.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

That marks substantial growth since July 2018, when only 970 medical institutions were registered to offer online care.

Still, the health ministry has not decided whether to make the changes permanent, while the national medical association is less than enthusiastic, citing concerns about misdiagnosis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We should be extremely cautious about using evidence drawn from telemedicine in the emergency situation for consideration of how it should be after the coronavirus infection wanes,” Japan Medical Association President Toshio Nakagawa tells Reuters. He was vice-president at the time of the interview.

Analysts say telemedicine can also put smaller clinics at a financial disadvantage.

Goichiro Toyoda, representative director and a medical doctor at Medley, agrees doctors can better check first-time patients in person but says telemedicine suits patients who want second opinions, have trouble visiting hospitals or need long-term treatments.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“Telemedicine will not replace face-to-face treatment,” says Dr. Toyoda. “But I’ve been stressing the importance of it becoming an option.”

Pages: 1 2 | Single Page

Filed Under: Technology Tagged With: International, Japan, patient care, Technology, telemedicine

You Might Also Like:
  • Telemedicine Company Wins Order Putting Texas Remote Treatment Rule on Hold
  • Japan PM’s Advisers Urge Annual Review of Drug Prices
  • Tight RA Control Via Telemedicine Noninferior to Conventional Clinic Visits
  • Telehealth Visits May Be an Option After Surgery

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)